Suppression of allograft rejection is central to successful organ transplantation; thus,
immunosuppressive agents are crucial for successful allograft function. Immunosuppressive drugs …

Chronic rejection or chronic allograft nephropathy (CAN) is the major cause of failure of
kidney transplants other than patient death, and has been extensively reviewed (1–5). CAN is …

PURPOSE: In cadaveric renal transplantation a period of delayed graft function postoperatively
is not uncommon and often associated with a poor outcome. We reviewed the biology of …

The Banff 97 working classification of renal allograft pathology. Background Standardization
of renal allograft biopsy interpretation is necessary to guide therapy and to establish an …

The 9th Banff Conference on Allograft Pathology was held in La Coruna, Spain on June 23–29,
2007. A total of 235 pathologists, clinicians and scientists met to address unsolved …

Background Immunosuppressive regimens with the fewest possible toxic effects are desirable
for transplant recipients. This study evaluated the efficacy and relative toxic effects of four …

We prospectively studied kidney transplants that progressed to failure after a biopsy for clinical
indications, aiming to assign a cause to every failure. We followed 315 allograft recipients …

… HALLORAN PF, WADGYMAR A, RITCHIE 5, FALK J, SOLEZ K, SRINIVASA NS: The
significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-…

The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15–21
July 2005. Major outcomes included the elimination of the non-specific term ‘chronic allograft …

… Halloran et al. in the early 1990s reported a triad of allograft dysfunction, neutrophils in
peritubular capillaries, and antibody against donor class I HLA antigens which defined an entity …